Unflinching focus on growth.
SPAC Leadership
We invest in the future—and it shows. We’re the leading bank that underwrites, advises, manages, and sponsors special purpose acquisition companies (SPACs).
With a 16-year history, over 80 SPACs underwritten and zero liquidations, Chardan is an authority on this powerful investment vehicle.
* Based on aggregate deal count reported by spacinsider.com for 2016, 2017, and 2018, inclusive.
* Based on aggregate deal count reported by spacinsider.com for 2016, 2017, and 2018, inclusive.
Healthcare
We specialize in biotech and healthcare technologies—enabling companies that deliver radical breakthroughs to get the funding they need.
FinTech
We bring two decades of experience of FinTech domain expertise, ranging from advising the largest financial institutions to younger, innovative FinTech firms.
Emerging Growth
We partner with innovators to help them successfully navigate the path from early-stage venture to larger public company.
Amplify your success with Chardan.
-
Generate Ideas
Identify unique opportunities in cutting-edge verticals with access to our world-class research.
-
Raise Capital
Attain financing on your private or public company—from equity, debt, or convertible funding to IPO.
-
Get Advice
Receive in-depth strategic advice on a range of services, from M&A to integrated capital markets.
-
Make Connections
Tap into our exclusive global network through corporate access meetings, conferences, and events.
Proven success. Lasting relationships.
Featured Story
REGENXBIO
A leader in the biotech industry, REGENXBIO is developing technologies critical to the success of innovative gene therapy products with the potential to cure a range of devastating diseases. Find out how Chardan enabled the growth of this groundbreaking platform.
Insights, happenings, and connections.
Work at Chardan.
Our departments include:
- Research
- Investment Banking
- Institutional Equities
- Operations
Thank You!
We've received your information, and we're processing your request.